cgp 28392 has been researched along with nimodipine in 3 studies
| Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (nimodipine) | Trials (nimodipine) | Recent Studies (post-2010) (nimodipine) |
|---|---|---|---|---|---|
| 76 | 1 | 2 | 2,936 | 317 | 597 |
| Protein | Taxonomy | cgp 28392 (IC50) | nimodipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 0.11 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.19 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 1.736 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 3.38 | |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | 0.0298 | |
| Voltage-dependent L-type calcium channel subunit beta-2 | Homo sapiens (human) | 0.0298 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 7.15 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 0.0699 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 1.243 | |
| Bile acid receptor | Homo sapiens (human) | 8.96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunert-Radek, J; Lyson, K; Pawlikowski, M; Stepien, H | 1 |
| Dannies, PS; Law, GJ; Pachter, JA | 1 |
| Bevan, JA; Hwa, JJ | 1 |
3 other study(ies) available for cgp 28392 and nimodipine
| Article | Year |
|---|---|
Effects of calcium channel modulators on the proliferation of mouse spleen lymphocytes in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Chloride; Cell Division; DNA; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Nimodipine; Pyridines; Spleen | 1990 |
Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Radioisotopes; Dihydropyridines; Female; In Vitro Techniques; Inositol Phosphates; Nimodipine; Perfusion; Prolactin; Pyridines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Thyrotropin-Releasing Hormone | 1991 |
Dihydropyridine calcium agonists selectively enhance resistance artery myogenic tone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Calcium; In Vitro Techniques; Ion Channels; Male; Nimodipine; Potassium; Pyridines; Rabbits; Vasoconstriction | 1986 |